[PDF][PDF] Phosphorylation of serine 10 in histone H3 is functionally linked in vitro and in vivo to Gcn5-mediated acetylation at lysine 14

WS Lo, RC Trievel, JR Rojas, L Duggan, JY Hsu… - Molecular cell, 2000 - cell.com
Multiple covalent modifications exist in the amino-terminal tails of core histones, but whether
a relationship exists between them is unknown. We examined the relationship between …

Structure of Tetrahymena GCN5 bound to coenzyme A and a histone H3 peptide

JR Rojas, RC Trievel, J Zhou, Y Mo, X Li, SL Berger… - Nature, 1999 - nature.com
Gene activation is a highly regulated process that requires the coordinated action of proteins
to relieve chromatin repression and to promote transcriptional activation. Nuclear histone …

Crystal structure and mechanism of histone acetylation of the yeast GCN5 transcriptional coactivator

RC Trievel, JR Rojas, DE Sterner… - Proceedings of the …, 1999 - National Acad Sciences
The yeast GCN5 (yGCN5) transcriptional coactivator functions as a histone acetyltransferase
(HAT) to promote transcriptional activation. Here, we present the high resolution crystal …

Formation, distribution, and elimination of infliximab and anti-infliximab immune complexes in cynomolgus monkeys

JR Rojas, RP Taylor, MR Cunningham… - … of Pharmacology and …, 2005 - ASPET
Infliximab (IFX) is a chimeric IgG1 monoclonal antibody specific for human tumor necrosis
factor-α that is approved in the United States and Europe for the treatment of rheumatoid …

[HTML][HTML] Crystal structure of the histone acetyltransferase domain of the human PCAF transcriptional regulator bound to coenzyme A

A Clements, JR Rojas, RC Trievel, L Wang… - The EMBO …, 1999 - embopress.org
The human p 300/C BP‐a ssociating f actor, PCAF, mediates transcriptional activation through
its ability to acetylate nucleosomal histone substrates as well as transcriptional activators …

Open-label, pilot protocol of patients with rheumatoid arthritis who switch to infliximab after an incomplete response to etanercept: the opposite study

…, P Callegari, S Visvanathan, J Rojas… - Annals of the …, 2007 - ard.bmj.com
Objective: To incorporate a new trial design to examine clinical response, cytokine expression
and joint imaging in patients with rheumatoid arthritis (RA) switching from etanercept to …

E-selectin, interleukin 18, serum amyloid a, and matrix metalloproteinase 9 are associated with clinical response to golimumab plus methotrexate in patients with …

S Visvanathan, C Wagner, J Rojas, J Kay… - The Journal of …, 2009 - jrheum.org
Objective. To assess the effect of golimumab (human monoclonal antibody to tumor necrosis
factor-α) plus methotrexate (MTX) on selected inflammatory biomarkers, and to determine if …

[PDF][PDF] Structure of a Leu3-DNA complex: recognition of everted CGG half-sites by a Zn2Cys6 binuclear cluster protein

MX Fitzgerald, JR Rojas, JM Kim, GB Kohlhaw… - Structure, 2006 - cell.com
Gal4 is the prototypical Zn 2 Cys 6 binuclear cluster transcriptional regulator that binds as a
homodimer to DNA containing inverted CGG half-sites. Leu3, a member of this protein family, …

[BOOK][B] Crystal structural analysis of a histone acetyltransferase from tetrahymena

JR Rojas - 2000 - search.proquest.com
INFORMATION TO USERS Page 1 INFORMATION TO USERS This manuscript has been
reproduced from the microfilm master. UMI films the text directly from the original or copy …

ANTI-INFLIXIMAB ANTIBODIES IN CROHN'S DISEASE PATIENTS ARE SPECIFIC AND DO NOT CROSS-REACT WITH OTHER THERAPEUTIC ANTIBODIES: 774

JR Rojas, D McCabe, RH Diamond… - Official journal of the …, 2004 - journals.lww.com
Purpose: Infliximab (IFX) is a chimeric IgG1 antibody approved for the treatment of rheumatoid
arthritis and Crohn's disease (CD). A small percentage of patients receiving IFX develop …